Please login to the form below

Not currently logged in
Email:
Password:

Roche's Annual General Meeting

Roche's 2008 Annual Report and financial statements have been approved by shareholders
According to the Roche Global website, Roche's Annual General Meeting, which was held in Basel on March 10, has approved all the board of Directors' proposals. The 703 shareholders in attendance, representing 90.2 per cent of a total of 160,000,000 bearer shares, approved the 2008 Annual Report and financial statements. They also authorised a +9 per cent increase in the dividend to 5.00 Swiss francs per share and non-voting equity. With this increase, the payout ratio rises to 49 per cent, which means that about half of net income will be paid out to shareholders. Franz Humer, André Hoffmann and John Irving Bell were re-elected to the board of directors for a further three-year term of office.

12th March 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics